These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9692835)

  • 1. Structure/activity studies with thiazolidinyl- and perhydrothiazinylphosphamide ester.
    Voelcker G; Hohorst HJ
    J Cancer Res Clin Oncol; 1998; 124(6):297-300. PubMed ID: 9692835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazine.
    Voelcker G; Pfeiffer B; Schnee A; Hohorst H
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):74-8. PubMed ID: 10664245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.
    Voelcker G; Bielicki L; Hohorst HJ
    J Cancer Res Clin Oncol; 1997; 123(11-12):623-31. PubMed ID: 9620221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
    J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the alkylating function of aldo-Ifosfamide on the anti-tumor activity.
    Voelcker G
    Anticancer Drugs; 2018 Jan; 29(1):75-79. PubMed ID: 29219879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
    Gugova RG; Raikov ZD; Zakhariev SG; Demirov GD; Todorov DK; Ilarionova MV
    Drugs Exp Clin Res; 1989; 15(10):497-500. PubMed ID: 2632217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ; Farquhar D
    J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF; Schmid SM; Waud WR
    Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-ones.
    Hadfield JA; Pavlidis VH; McGown AT; Whitworth C; Perry PJ; Fox BW
    Anticancer Drugs; 1994 Oct; 5(5):533-8. PubMed ID: 7858285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
    Okada H; Kato M; Koyanagi T; Mizuno K
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of 9-acyloxyellipticines.
    Harada N; Ozaki K; Oda K; Nakanishi N; Ohashi M; Hashiyama T; Tsujihara K
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1156-62. PubMed ID: 9246749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low toxicity cancer chemotherapy by suicide inactivation of DNA polymerase alpha holoenzyme: first results with new thiazolidinyl- and perhydrothiazinyl-ethyl-N-mustard-phosphamide esters.
    Hohorst HJ; Bielicki L; Müller K; Voelcker G
    J Cancer Res Clin Oncol; 1988; 114(3):309-11. PubMed ID: 3384844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the formation of 4-[N,N-bis(2-chloroethyl)amino]phenyl acetic acid esters of hecogenin and aza-homo-hecogenin and their antileukemic activity.
    Camoutsis C; Trafalis D; Pairas G; Papageorgiou A
    Farmaco; 2005 Oct; 60(10):826-9. PubMed ID: 16139280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
    Narita T; Yaguchi S; Komatsu T; Takase M; Hoshino A; Inaba M; Tsukagoshi S
    Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preclinical trials of polyplatillen, the antitumor activity of a complex platinum compound with DNA on a leukemia P388 model in a HEp-2 cell culture (1)].
    Shalimov SA; Trokhimenko EP; Dziublik IV; Keĭsevich LV; Volchenskova II; Kogut GI; Glukhen'kaia GT
    Lik Sprava; 1992; (11-12):114-7. PubMed ID: 1292205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor properties of activated cyclophosphamide analogues.
    Borch RF; Canute GW
    J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.